CHRU-Nancy, Nancy, France
CHRU-Nancy, Nancy, France.
Clin J Am Soc Nephrol. 2022 Nov;17(11):1588-1597. doi: 10.2215/CJN.06140522.
Late stages of CKD are characterized by significant symptom burden. This study aimed to identify subgroups within the 5-year trajectories of symptom evolution in patients with CKD and to describe associated patient characteristics and outcomes.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Among 2787 participants (66% men) with eGFR <60 ml/min per 1.73 m enrolled in the CKD-Renal Epidemiology and Information Network (CKD-REIN) cohort study from July 2013 to May 2016, we assessed symptoms annually using the Kidney Disease Quality of Life-36 (KDQOL-36) questionnaire until December 2020. A total of 9121 measures were reported over follow-up; all participants had symptoms scored for at least one time point. We used a joint latent class-mixed model to distinguish profiles of symptom trajectories.
Patient mean age (±SD) at baseline was 67±13 years, and mean eGFR was 33±13 ml/min per 1.73 m. The prevalence of each symptom ranged from 24% (chest pain) to 83% (fatigue), and 98% of participants reported at least one symptom. After a median (interquartile range) follow-up of 5.3 (3.4-6.0) years, 690 participants initiated KRT, and 490 died before KRT. We identified two profiles of symptom trajectories: a "worse symptom score and worsening trajectory" in 31% of participants, characterized by a low initial symptom score that worsened more than ten points over time, and a "better symptom score and stable trajectory" in 69% of participants, characterized by a high initial score that remained stable. Participants in the worse symptom score and worsening trajectory group had more risk factors for CKD progression at baseline, worse quality of life, and a higher risk of KRT and death before KRT than other participants.
This study highlights a significant worsening of symptoms in about one third of the participants, whereas the majority reported low symptom severity throughout the study.
慢性肾脏病(CKD)晚期的特点是症状负担显著。本研究旨在确定 CKD 患者症状演变的 5 年轨迹中的亚组,并描述相关患者特征和结局。
设计、设置、参与者和测量:在 2013 年 7 月至 2016 年 5 月期间,来自 CKD-肾脏流行病学和信息网络(CKD-REIN)队列研究的 2787 名(66%为男性)肾小球滤过率(eGFR)<60 ml/min/1.73 m2 的参与者中,我们每年使用肾脏病生活质量-36(KDQOL-36)问卷评估一次症状,直到 2020 年 12 月。在随访期间共报告了 9121 次测量值;所有参与者至少有一次报告了症状。我们使用联合潜在类别混合模型来区分症状轨迹的特征。
患者的基线平均年龄(±SD)为 67±13 岁,平均 eGFR 为 33±13 ml/min/1.73 m2。每种症状的患病率从 24%(胸痛)到 83%(疲劳)不等,98%的参与者报告至少有一种症状。在中位数(四分位间距)为 5.3(3.4-6.0)年的随访后,690 名参与者开始进行肾脏替代治疗(KRT),490 名参与者在 KRT 前死亡。我们确定了两种症状轨迹特征:31%的参与者存在“症状评分更差且轨迹恶化”,表现为初始症状评分较低,随时间推移恶化超过 10 分;69%的参与者存在“症状评分更好且轨迹稳定”,表现为初始评分较高且保持稳定。与其他参与者相比,“症状评分更差且轨迹恶化”组的参与者在基线时更具有 CKD 进展的危险因素,生活质量更差,并且在 KRT 前发生 KRT 和死亡的风险更高。
本研究强调了大约三分之一的参与者的症状显著恶化,而大多数参与者在整个研究过程中报告了低严重程度的症状。